HomeNewsNewsletter
Print-friendly version

Questions about Tamiflu

Posted on Monday, 14 December 2009 08:48AM by
The effectiveness of the swine flu antiviral Tamiflu was being questioned amid disarray over government plans to inoculate more than three million young children against the bug.
Research published in the British Medical Journal found that the antiviral could cut the length of time people have symptoms by about a day, or less, but said there was no clear evidence that it prevented complications.  It is known that Tamiflu can cause nightmares and other distressing symptoms.
Under the government's mass vaccination programme, GPs have been receiving £5.25 per patient for at-risk groups.  Ministers said they have asked primary care trusts to put local plans into place to vaccinate more than three million healthy children under five across the UK.